1. Ford AC, Moayyedi P, Hanauer SB. Ulcerative colitis. BMJ. 2013 Feb 5;346:f432.
2. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012 Nov 3;380(9853):1606-19.
6. Okada Y, Yamazaki K, Umeno J, Takahashi A, Kumasaka N, Ashikawa K, Aoi T, Takazoe M, Matsui T, Hirano A, Matsumoto T, Kamatani N, Nakamura Y, Yamamoto K, Kubo M. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Gastroenterology. 2011 Sep;141(3):864-871.e1-5.
7. Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis. 2014 Aug;8(8):717-25.
8. Sicilia B, Arribas F, Nerín J, López Miguel C, Vicente R, Gomollón F. Risk factors for ulcerative colitis: A population-based, case-control study in Spain. J Crohns Colitis. 2008 Jun;2(2):158-61.
9. Ananthakrishnan AN. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013 Jun;9(6):367-74.
15. Harrison T. Longo D. Kasper D. et al. Harrison’s Principle of Internal Medicine. 19th ed. USA: Mc-Graw Hill;2015. P. 1947-1965.
18. Scoglio D, Ahmed Ali U, Fichera A. Surgical treatment of ulcerative colitis: ileorectal vs ileal pouch-anal anastomosis. World J Gastroenterol. 2014 Oct 7;20(37):13211-8.
24. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524.
27. Alhusayen RO, Juurlink DN, Mamdani MM, Morrow RL, Shear NH, Dormuth CR; Canadian Drug Safety and Effectiveness Research Network. Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. J Invest Dermatol. 2013 Apr;133(4):907-12.